The patient perspective on remission in rheumatoid arthritis: ‘You’ve got limits, but you’re back to being you again’
- 1 June 2015
- journal article
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 74 (6) , 1004-1010
Abstract
Objectives The aim of rheumatoid arthritis (RA) treatment is remission. As treatment should be targeted at outcomes relevant to patients, it is important to understand how patients perceive remission, and to assess whether the current definition of remission adequately reflects these perceptions. The objective of this study is to explore the patient perspective on remission in RA. Methods Nine focus-group discussions in Austria, The Netherlands and UK were conducted, including patients in American College of Rheumatology (ACR)/ European League of Rheumatology (EULAR) remission, self-declared remission and in moderate/high disease activity. Moderators employed a prespecified interview guide helped to engage patients in a discussion on their experience with remission. Inductive thematic analysis was performed within each country, and identified themes were discussed across countries. Results 47 RA patients (66% women, disease duration 9 years) participated. Three major themes of patient-perceived remission emerged: (1) symptoms would either be absent or strongly reduced, (2) impact of the disease on daily life would diminish by increased independence, ability to do valued activities, improved mood and ability to cope; (3) leading to a return to normality, including work, family role and perception of others. Patients felt the concept of remission was influenced by ageing, side effects of medication, comorbidities, accrued damage to joints and disease duration. Opinions on duration of state, the role of medication and measurement instruments varied widely. Conclusions Patients characterise remission by the absence or reduction of symptoms, but more directly by decreased daily impact of their condition and the feeling of a return to normality. The next step is to study whether an additional patient-perceived measure of remission may add value to the ACR/EULAR definition of remission.Keywords
This publication has 23 references indexed in Scilit:
- American College of Rheumatology/European League Against Rheumatism Provisional Definition of Remission in Rheumatoid Arthritis for Clinical TrialsAnnals of the Rheumatic Diseases, 2011
- Collaboration with patients in the design of patient‐reported outcome measures: Capturing the experience of fatigue in rheumatoid arthritisArthritis Care & Research, 2010
- Fatigue is a reliable, sensitive and unique outcome measure in rheumatoid arthritisRheumatology, 2009
- Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendationsAnnals of the Rheumatic Diseases, 2008
- Responsiveness of patient reported outcomes including fatigue, sleep quality, activity limitation, and quality of life following treatment with abatacept for rheumatoid arthritisAnnals of the Rheumatic Diseases, 2008
- Similar prediction of mortality by the health assessment questionnaire in patients with rheumatoid arthritis and the general populationAnnals of the Rheumatic Diseases, 2004
- Does social disadvantage contribute to the excess mortality in rheumatoid arthritis patients?Annals of the Rheumatic Diseases, 1999
- Modified disease activity scores that include twenty-eight-joint counts development and validation in a prospective longitudinal study of patients with rheumatoid arthritisArthritis & Rheumatism, 1995
- The American college of rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trialsArthritis & Rheumatism, 1993
- Severe functional declines, work disability, and increased mortality in seventy‐five rheumatoid arthritis patients studied over nine yearsArthritis & Rheumatism, 1984